Video Games Trigger Dangerous Arrhythmias in Some Children Video Games Trigger Dangerous Arrhythmias in Some Children
Although such events are rare in children and adolescents, they are on the rise and can be lethal, experts caution.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - October 11, 2022 Category: Pediatrics Tags: Cardiology News Source Type: news
Rare Cause of Arrhythmia and Seizures in a Late-Preterm Newborn
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - October 1, 2022 Category: Pediatrics Source Type: news
New-Onset A-Fib Profiled in Patients Hospitalized With COVID-19
WEDNESDAY, Sept. 28, 2022 -- New-onset atrial fibrillation (AF) has been reported in 5.4 percent of patients hospitalized with COVID-19 across the United States, according to a study published in a recent issue of Circulation: Arrhythmia and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2022 Category: Pharmaceuticals Source Type: news
Atrial fibrillation: Two music genres linked to 'potentially dangerous' heart arrhythmias
The evidence suggests music engages not only with the brain, but may also affect changes in heart variability which could set the stage for stroke. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2022 Category: Consumer Health News Source Type: news
ESC Updates Guidelines for Ventricular Arrhythmia, Sudden Death ESC Updates Guidelines for Ventricular Arrhythmia, Sudden Death
ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have undergone an important overhaul since the 2015 edition.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 16, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
PM ₂.₅ Exposure Linked to Ventricular Arrhythmias in Teens
WEDNESDAY, Sept. 14, 2022 -- For adolescents, exposure to fine particulate matter (fine particles with aerodynamic diameters ≤2.5 µm [PM2.5]) is associated with an acute increase in the number of ventricular arrhythmias, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2022 Category: Pharmaceuticals Source Type: news
Breathing Dirty Air Can Cause Teens' Hearts to Skip a Beat
WEDNESDAY, Sept. 14, 2022 -- Air pollution may cause irregular heart rhythms in otherwise healthy teens within two hours of exposure, a new study shows.
Irregular heart rhythms, or arrhythmias, occur when the heart’s electrical impulses don ' t... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2022 Category: General Medicine Source Type: news
Smartphone AF Screening Doubles Detection: eBRAVE-AF Smartphone AF Screening Doubles Detection: eBRAVE-AF
Use of smartphone-based self-screening for atrial fibrillation increased the rate of detection and treatment of AF among older adults without the arrhythmia but at high risk for stroke.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 13, 2022 Category: Neurology Tags: Cardiology News Source Type: news
Biosense Webster Launches the OCTARAY ™ Mapping Catheter with TRUEref™ Technology
IRVINE, CA – September 6, 2022 – Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the OCTARAY™ Mapping Catheter with TRUEref™ Technology powered by the CARTO™ 3 Version 7 System. The OCTARAY™ Mapping Catheter was developed for the mapping of cardiac arrhythmias, including atrial fibrillation (AFib). The catheter has eight splines with improved electrode spacing options to provide shorter and more efficient mapping times than PENTARAYTM NAV ECO Mapping Catheter, which may shorten overall ablation procedure times.[2],[8],[‡] AFib is the most common type of cardi...
Source: Johnson and Johnson - September 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Medtronic completes acquisition of Affera
Acquisition adds mapping and navigation platform to company's cardiac ablation portfolio and brings an integrated system of diagnostic and therapeutic tools to address a broad spectrum of arrhythmias
DUBLIN, Aug. 30, 2022 -- (Healthcare Sales & Marketin... Devices, Cardiology, Mergers & Acquisitions Medtronic, Affera , Affera Prism-1, cardiac mapping (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2022 Category: Pharmaceuticals Source Type: news
A new type of defibrillator met safety, effectiveness goals in global clinical study
ROCHESTER, Minn. — A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular a rrhythmias. The findings were presented during a late-breaking session at the European Society of Cardiology Congress and were simultaneously published in The New England Journal of Medicine. Arrhythmias such as ventricular fibrillation and… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - August 29, 2022 Category: Hospital Management Source Type: news
Cannabis for Pain Linked to Slight Risk for Arrhythmia Cannabis for Pain Linked to Slight Risk for Arrhythmia
Results of a case-control study showed a small increase in various arrhythmias in chronic pain patients given a medical cannabis prescription, although the absolute risk was small.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - August 26, 2022 Category: Psychiatry Tags: Cardiology News Source Type: news
U.S. FDA Approves IMBRUVICA ® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
August 24, 2022 (HORSHAM, PA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy. This milestone marks the first pediatric indication for IMBRUVICA® and the introduction of a new oral suspension formulation for patients ages one to less than 12. IMBRUVICA® is now the first FDA-approved therapy for these younger patients who previously had no approv...
Source: Johnson and Johnson - August 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Medical Marijuana for Pain Is Linked to Slight Rise in Heart Trouble
TUESDAY, Aug. 23, 2022 -- People who use medical marijuana to treat chronic pain may have a slightly heightened risk of heart arrhythmias, a preliminary study suggests.
Researchers found that among 1.6 million people with chronic pain, those... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 23, 2022 Category: General Medicine Source Type: news
Higher Cardiac COVID Risks in Pregnancy Require Team Care Higher Cardiac COVID Risks in Pregnancy Require Team Care
Pregnant women are at elevated risk for cardiac complications of COVID-19, including myocardial injury, arrhythmias, and heart failure, and require multidisciplinary team care, a new review concludes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 15, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
